medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (3)

Tinea cruris: a 10-year retrospective study of 66 patients

Torres ZALM, Cabral RGA, Betancourt MPC, Vega SDC, Arenas GR
Full text How to cite this article

Language: Spanish
References: 10
Page: 190-194
PDF size: 321.39 Kb.


Key words:

tinea cruris, dermatophytes, T. rubrum.

ABSTRACT

Background: tinea cruris, a common dermatophytosis, accounts for 5% of dermatology consultations. It primarily affects men between their third and fifth decades of life. Globally, Trichophyton rubrum is the most prevalent causative agent, followed by Trichophyton mentagrophytes and Epidermophyton floccosum.
Objectives: to present the epidemiological data and identify the most common causative agent of tinea cruris cases seen at the Mycology Section of a general hospital in Mexico City.
Methods: this was a retrospective, cross-sectional, descriptive, and observational study involving 66 patients suspected of tinea cruris. These patients were evaluated over a 10-year period and referred to the Mycology Section at Dr. Manuel Gea González General Hospital.
Results: of the 66 included patients, 61 had a positive direct examination for filaments ± spores, and 34 had a positive dermatophyte culture. T. rubrum predominated (48.48%), followed by T. tonsurans (1.51%) and E. floccosum (1.51%). The predominant sex was male, with 49 patients (74.24%), and the mean age was 45.7 years. The most prevalent comorbidities were HIV (12.12%) and diabetes (9.09%). One patient (7.57%) was on antifungal therapy, and one (7.57%) was undergoing immunosuppressive therapy.
Conclusions: this study reports that tinea cruris predominantly affected males between their fourth and sixth decades of life, with a variable duration of evolution. The most prevalent causative agent was T. rubrum .


REFERENCES

  1. Arenas-Guzmán R, Dermatología. Atlas, diagnóstico y tratamiento,8ª ed., México, McGraw Hill Interamericana, 2024, pp.460, 463.

  2. Bonifaz-Trujillo J, Micología médica básica, 5ª ed., México, Mc-Graw Hill, 2020, pp. 110, 120.

  3. Barac A, Stjepanovic M, Krajisnik S et al., Dermatophytes: updateon clinical epidemiology and treatment, Mycopathologia2024; 189(6):101. Disponible en: https://doi.org/10.1007/s11046-024-00909-3.

  4. Arenas-Guzmán R, Micología médica ilustrada, 6ª ed., México,McGraw Hill, 2019, pp. 80-81.

  5. Vega-Sánchez C, Vega-Nava C y Arenas-Guzmán R, Tiña de ingleen 114 pacientes. Estudio en un hospital general en el periodo1994 a 2014, Dermatología cmq 2016; 14(2):106-9.

  6. Chanyachailert P, Leeyaphan C y Bunyaratavej S, Cutaneousfungal infections caused by dermatophytes and non-dermatophytes:an updated comprehensive review of epidemiology,clinical presentations, and diagnostic testing, Journal of Fungi2023; 9(6):669.

  7. De Hoog GS, Dukik K, Monod M et al., Toward a novel multilocusphylogenetic taxonomy for the dermatophytes, Mycopathologia2017; 182:5-31. Disponible en: https://doi.org/10.1007/s11046-016-0073-9.

  8. Gupta AK, Chaudhry M y Elewski B, Tinea corporis, tinea cruris,tinea nigra, and piedra, Dermatologic Clinics 2023; 21(3):395-400. doi:10.1016/s0733-8635(03)00031-7.

  9. Hill RC, Caplan AS, Elewski B, Gold JAW, Lockhart SR, SmithDJ et al., Expert panel review of skin and hair dermatophytosesin an era of antifungal resistance, Am J Clin Dermatol 2024;25(3):359-89.

  10. Khurana A, Agarwal A, Agrawal D et al., Effect of different itraconazoledosing regimens on cure rates, treatment duration,safety, and relapse rates in adult patients with tinea corporis/cruris: a randomized clinical trial, jama Dermatology 2022;158(11):1269-78. Disponible en: https://doi.org/10.1001/jamadermatol.2022.3745.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2025;23